Arabic Arabic English English French French German German

Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir

When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.

Published this week in Cell Reports, this finding – from Gaetano Montelione, a professor of chemistry and chemical biology at Rensselaer Polytechnic Institute, and his collaborators at the Icahn School of Medicine at Mount Sinai and the University of Texas at Austin – raises the potential for repurposing available drugs as COVID-19 antivirals in cases where a vaccine isn’t practical or effective.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Florida mulls decision to discontinue no-fault insurance

Next Post

Independent living and falls detection technology recognised with LangBuisson Award

Related Posts